This inventor holds 1 USPTO granted patent. Top assignee: Pharmabcine Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Cheonho Park: Innovator in Antibody Research
Introduction
Cheonho Park is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work is recognized for its potential applications in medical treatments.
Latest Patents
Cheonho Park holds a patent for an "ANTI-TIE2 ANTIBODY AND USE THEREOF." This innovation represents a step forward in therapeutic options for various diseases, showcasing his expertise in antibody research. He has 1 patent to his name, reflecting his commitment to advancing scientific knowledge.
Career Highlights
Currently, Cheonho Park is associated with Pharmabcine Inc., a company dedicated to developing innovative therapies. His role at Pharmabcine Inc. allows him to collaborate with other talented professionals in the field. His work is instrumental in pushing the boundaries of what is possible in biotechnology.
Collaborations
Cheonho Park has worked alongside talented colleagues, including Eun-Ah Lee and Beom Yong Park. These collaborations enhance the research environment and contribute to the success of their projects.
Conclusion
Cheonho Park is a distinguished inventor whose work in antibody research is paving the way for new medical advancements. His contributions to Pharmabcine Inc. and the scientific community are commendable.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile